Regulation of Bcl-2 oncoprotein levels with differentiation of human neuroblastoma cells.

Hanada, M; Krajewski, S; Tanaka, S; Cazals-Hatem, D; Spengler, B A; Ross, R A; Biedler, J L; Reed, J C

Hanada, M; Krajewski, S; Tanaka, S; Cazals-Hatem, D; Spengler, B A; Ross, R A; Biedler, J L; Reed, J C.

Affiliation

Hanada M; La Jolla Cancer Research Foundation, Cancer Research Center, California 92037.

Cancer Res ; 53(20): 4978-86, 1993 Oct 15.

Article in En | MEDLINE | ID: mdl-8402688

Subject(s)

Antineoplastic Agents/toxicity; Gene Expression Regulation, Neoplastic; Neuroblastoma/metabolism; Neuroblastoma/pathology; Oncogenes; Proto-Oncogene Proteins/biosynthesis; Carcinogens/pharmacology; Cell Differentiation/drug effects; Cell Division/drug effects; Cell Line; Cell Survival/drug effects; Clone Cells; Drug Resistance; Humans; Kinetics; Phorbol Esters/pharmacology; Proto-Oncogene Proteins/metabolism; Proto-Oncogene Proteins c-bcl-2; Tetradecanoylphorbol Acetate/pharmacology; Time Factors; Transfection; Tretinoin/pharmacology; Tumor Cells, Cultured

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Oncogenes / Gene Expression Regulation, Neoplastic / Proto-Oncogene Proteins / Neuroblastoma / Antineoplastic Agents Limits: Humans Language: En Journal: Cancer Res Year: 1993 Type: Article

Search on Google

Add to My VHL

XML

PubMed Links